Journals
Topics
Contributed Content
July 14, 2017
July 10, 2017
Latest News
July 20, 2017 | Mary Caffrey
The data confirm what Medicaid beneficiaries report and what a study by a Wharton School professor found: physicians' willingness to take on Medicaid patients is directly related to reimbursement rates.
July 20, 2017 |
Zirui Song, MD, PhD, resident at Massachusetts General Hospital, discussed his research interests, which center on strategies to control healthcare spending while improving the quality of care. He also expressed the importance of examining health equity within the United States healthcare system.
July 20, 2017 | Mary Caffrey
The study found that no matter their eating pattern, participants tended to add weight gradually until age 60, then lose it gradually. But those who had most of their calories earlier in the day gained less and lost weight more rapidly after age 60.
July 20, 2017 | Surabhi Dangi-Garimella, PhD
Researchers at the University of Pennsylvania have recognized that narrow provider networks are quite likely to exclude National Cancer Institute–Designated Cancer Centers or National Comprehensive Cancer Network Cancer Centers, which could prevent patient access to high-quality cancer care.
July 20, 2017 | Christina Mattina
In a recently released position statement, the American Society of Clinical Oncology (ASCO) has outlined a pathway that would address the rising costs of cancer drugs in the United States.
July 20, 2017 | AJMC Staff
July 20, 2017 |
Andrew Rhinehart, MD, chief medical officer at Glytec, discusses the transition from intermediate outcomes in diabetes research of glycemic results to harder outcomes that will benefit the patient financially and through their care.
July 19, 2017 | Alison Rodriguez
The FDA recently approved Vosevi—a fixed-dose combination tablet containing FDA-approved sofosbuvir and velpatasvir, and a new drug, voxilaprevi—to treat adults with the hepatitis C virus who do not have cirrhosis (liver disease).
July 19, 2017 | Alison Rodriguez
The majority of patients with chronic obstructive pulmonary disease (COPD) do not receive positive airway pressure (PAP) therapy despite its effectiveness in reducing hospitalizations, according to research.
July 19, 2017 | Surabhi Dangi-Garimella, PhD
Researchers at the Beth Israel Deaconess Medical Center in Boston investigated the impact of patient engagement in evaluating their care visit notes and found patients and care partners who chose to provide feedback were enthusiastic about assisting with improving the accuracy of clinician notes.
July 19, 2017 | Christina Mattina
The National Quality Forum (NQF) has issued a report detailing the results of its experiment with including social risk factors in its risk adjustment models for performance measures.
July 19, 2017 | Mary Caffrey
If there's good news, it's that the rate of increase in number of individuals with diabetes seems to be slowing. But the disease is hitting hardest on the populations with the fewest resources to manage it.
July 19, 2017 | AJMC Staff
From the Journals
Dangi-Garimella
A poster discussion session at the 2017 Annual Meeting of the American Society of Clinical Oncology led by Katherine Van Loon, MD, MPH, examined retrospective surveillance data in 3 cancers: non–small cell lung cancer, head and neck cancer, and colorectal cancer.
Dangi-Garimella
At the 2017 American Society of Clinical Oncology Annual Meeting, oncologists heard from fellow experts on the best way to navigate the daunting challenge of payment reform.
Caffrey
Coverage from the first of 3 Peer Exchange™ discussions from the Diabetes Stakeholders Summit.
From Unexpected CV Benefits to Potential in Heart Failure: Insights and Outlook for SGLT2 Inhibitors
Caffrey
Coverage from the first of 3 Peer Exchange™ discussions from the Diabetes Stakeholders Summit.
Dangi-Garimella
A kickoff session on the first day of the 2017 American Society of Clinical Oncology Annual Meeting in Chicago turned in to a lively discussion on ensuring that the data used to inform patient care and create healthcare policies hold value, which could entail foraging real-world data captured in health records.
AJMC Staff
According to outcome results presented at a plenary session at the 2017 American Society of Clinical Oncology Annual Meeting, patients receiving routine outpatient chemotherapy for metastatic
solid tumors who self-reported 12 common symptoms via tablet computers experienced an overall survival benefit over those who received usual care.
AJMC Staff
A poster session at the 2017 American Society of Clinical Oncology Annual Meeting presented the trial details of IRONCLAD, a randomized phase 3 study of ibrutinib versus no consolidation following autologous hematopoietic stem cell transplantation for activated-B-cell subtype relapsed diffuse large B-cell lymphoma.
AJMC Staff
In a late-breaking abstract at the 2017 American Society of Clinical Oncology Annual Meeting, researchers presented an interim analysis of a randomized phase 2 trial of second- or third-line nivolumab, with or without ipilimumab, in patients with second- or third-line malignant pleural mesothelioma.
Three Months of Oxaliplatin-Based Adjuvant Therapy Noninferior to 6 Months in Stage III Colon Cancer
AJMC Staff
The International Duration Evaluation of Adjuvant chemotherapy (IDEA) collaboration found evidence to support the noninferiority of 3 versus 6 months oxaliplatin-based adjuvant therapy for capecitabine plus oxaliplatin for patients with stage III colon cancer.
Compendia
Know Your News
Formulary
Upcoming Partner Events
Most Popular
Interviews View More Interviews >>
Peer ExchangeView More Peer Exchange >>
AJMC Strategic Alliance
